Robertson Stephens Wealth Management’s Adaptive Biotechnologies ADPT Stock Holding History

Robertson Stephens Wealth Management’s Portfolio ADPT Stock Details ADPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.09M	Hold	97,218	–	–	0.05%	212
2026 Q1	$1.35M	Hold	97,218	–	–	0.04%	257
2025 Q4	$1.58M	Sell	97,218 -55,000	-36%	-$898K	0.04%	241
2025 Q3	$2.28M	Hold	152,218	–	–	0.07%	171
2025 Q2	$1.77M	Sell	152,218 -15,718	-9%	-$143K	0.06%	205
2025 Q1	$1.25M	Sell	167,936 -4,250	-2%	-$32.7K	0.04%	241
2024 Q4	$1.03M	Sell	172,186 -11,500	-6%	-$63.4K	0.04%	256
2024 Q3	$940K	Sell	183,686 -100	-0.1%	-$436	0.03%	288
2024 Q2	$665K	Hold	183,786	–	–	0.03%	283
2024 Q1	$590K	Hold	183,786	–	–	0.03%	316
2023 Q4	$901K	Sell	183,786 -16,000	-8%	-$73K	0.05%	235
2023 Q3	$1.09M	Hold	199,786	–	–	0.07%	197
2023 Q2	$1.34M	Sell	199,786 -2,925	-1%	-$21.7K	0.09%	166
2023 Q1	$1.79M	Buy	202,711 +21,000	+12%	+$185K	0.14%	137
2022 Q4	$1.39M	Sell	181,711 -450	-0.2%	-$3.5K	0.14%	143
2022 Q3	$1.3M	Hold	182,161	–	–	0.14%	127
2022 Q2	$1.47M	Buy	182,161 +450	+0.2%	+$3.96K	0.14%	124
2022 Q1	$2.52M	Buy	181,711 +4,175	+2%	+$65.6K	0.21%	92
2021 Q4	$4.98M	Sell	177,536 -2,000	-1%	-$61.3K	0.42%	54
2021 Q3	$6.1M	Hold	179,536	–	–	0.69%	34
2021 Q2	$7.33M	Sell	179,536 -7,000	-4%	-$272K	0.88%	24
2021 Q1	$7.51M	Sell	186,536 -25,400	-12%	-$1.37M	1.2%	21
2020 Q4	$12.5M	Sell	211,936 -57,250	-21%	-$2.95M	2.62%	7
2020 Q3	$13.1M	Sell	269,186 -209,793	-44%	-$8.82M	3.22%	6
2020 Q2	$23.2M	Sell	478,979 -58,116	-11%	-$2.12M	6.69%	1
2020 Q1	$14.9M	Buy	537,095 +404,179	+304%	+$11.3M	5.1%	2
2019 Q4	$3.98M	Buy	+132,916	New	+$3.82M	2.01%	11

Other funds holding ADPT

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

PCM

Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

AWM

Affinity Wealth Management Wilmington, Delaware $776M AUM 43.59% 1-Year Est. Return

FISPB

Fideuram - Intesa Sanpaolo Private Banking Turin $3.33B AUM

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

EWM

Edge Wealth Management New York $594M AUM 24.92% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

ETC

Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Robertson Stephens Wealth Management's ADPT Position: Q2 2026 in Review

Robertson Stephens Wealth Management held its Adaptive Biotechnologies (ADPT) position steady in Q2 2026 at 97,218 shares worth $2.09M. The position accounts for 0.05% of the portfolio, ranked #212.

Robertson Stephens Wealth Management first reported a position in ADPT in Q4 2019 and has held it in 27 quarters since. The position peaked at $23.2M in Q2 2020. 67 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

Robertson Stephens Wealth Management held 97,218 shares of Adaptive Biotechnologies worth $2.09M as of Q2 2026.
Robertson Stephens Wealth Management left its Adaptive Biotechnologies share count unchanged in Q2 2026.
Adaptive Biotechnologies made up 0.05% of Robertson Stephens Wealth Management's portfolio in Q2 2026, its #212 holding.
Robertson Stephens Wealth Management first reported a position in Adaptive Biotechnologies in Q4 2019 and has held it in 27 quarters since.
Robertson Stephens Wealth Management's Adaptive Biotechnologies position peaked at $23.2M in Q2 2020.
67 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on Robertson Stephens Wealth Management's 13F filing for Q2 2026, filed 29 Jul 2026.